Category: News Alert

News Alert

Senator Cassidy Expands 340B Inquiry to Two Major Contract Pharmacies

January 18, 2024 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) expanded his ongoing inquiry into 340B revenue with letters to two major contract pharmacies.

The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk, Arkansas Reach Temporary Deal Amid Contract Pharmacy Fight

January 4, 2024 Rich Daly, Editor in Chief Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

Novo Nordisk will lift restrictions in Arkansas on 340B providers’ contract pharmacy arrangements and Arkansas will suspend enforcement against the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

December 18, 2023 William Newton, Associate Editor/Senior Writer Views

Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.

Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance

December 14, 2023 Rich Daly, Editor in Chief Views

HRSA released a new web page with resources on the agency's 340B program patient definition and compliance guidelines.

In the wake of a high-profile federal court ruling casting doubt on the definition of eligible “patient” in the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Influential Senator Extends 340B Inquiry to Community Health Centers

November 16, 2023 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) expanded his ongoing inquiry into 340B revenue with letters to two major contract pharmacies.

The top Republican on an influential Senate committee today asked two community health centers to submit detailed financial information on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Medicare to Continue ASP Plus 6% for 340B Drugs in 2024

November 3, 2023 Rich Daly, Editor in Chief Views

In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.

Medicare Part B will continue to pay hospitals for 340B drugs at the rate of average sales price (ASP) plus [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Finalizes 340B Lump Sum Payment, Retains Offsetting Cuts Starting in 2026

November 2, 2023 Rich Daly, Editor in Chief Views

CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.

Medicare issued a final rule today to implement a $9 billion lump sum payment to 340B hospitals and to cut [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sandoz Is 28th Drugmaker to Adopt 340B Contract Pharmacy Restrictions

November 1, 2023 Tom Mirga, Editor at Large Views

Drugmaker Sandoz, a Novartis spin-off, became the 28th pharmaceutical company to implement 340B contract pharmacy restrictions.

Generic and biosimilar drugmaker Sandoz today became the 28th pharmaceutical company to place conditions on 340B pricing involving drug shipments [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Loosens 340B Contract Pharmacy Restrictions in Arkansas and Louisiana

October 31, 2023 William Newton, Associate Editor/Senior Writer Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Dispute Resolution Final Rule Enters Last Stage of Regulatory Review

October 19, 2023 Rich Daly, Editor in Chief Views

HRSA plans to host a webinar for federal grantees in the days leading up to the 2024 340B recertification period.

A final rule to implement the 340B administrative dispute resolution (ADR) process arrived this week at the last stage of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live